APA (7th ed.) Citation

Xu, D., Wang, H., Bao, Q., Jin, K., Liu, M., Liu, W., . . . Xing, B. The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: A phase II trial. Nature Portfolio.

Chicago Style (17th ed.) Citation

Xu, Da, et al. The Anti-PD-L1/CTLA-4 Bispecific Antibody KN046 Plus Lenvatinib in Advanced Unresectable or Metastatic Hepatocellular Carcinoma: A Phase II Trial. Nature Portfolio.

MLA (9th ed.) Citation

Xu, Da, et al. The Anti-PD-L1/CTLA-4 Bispecific Antibody KN046 Plus Lenvatinib in Advanced Unresectable or Metastatic Hepatocellular Carcinoma: A Phase II Trial. Nature Portfolio.